{
    "clinical_study": {
        "@rank": "92319", 
        "brief_summary": {
            "textblock": "Assess changes in the corneal cell count using Specular Microscopy following tretments with\n      Anti-VEGF injections"
        }, 
        "brief_title": "Measuring Corneal Cells With Specular Microscopy", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Retinal Diseases", 
        "condition_browse": {
            "mesh_term": "Retinal Diseases"
        }, 
        "detailed_description": {
            "textblock": "Patients with active Wet AMD often receive intraocular Anti-VEGF injections such as Macugen,\n      Lucentis and Avastin on a monthly basis for an extended period of time.  While these\n      medications are very effective at controlling the Choroidal Neovascularization associated\n      with this disease, the impact of monthly intravigtreal Anti-VEGF injections on the viability\n      of corneal endothelial cells has yet to be fully characterized.  The availability of CESM as\n      a diagnostic test that can be performed quickly and painlessly in the clinic offers a method\n      of tracking corneal endothelial cell count in this patient population."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Wet Age-related Macular Degeneration\n\n          -  Receiving monthly intraocular injections of Anti-VEGF medication for at least 3\n             months\n\n          -  Age greater than 50 years of age\n\n        Exclusion Criteria:\n\n          -  experiences adverse events"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects of either gender with an age greater than 50 years of age who have been receiving\n        intraocular Anti-VEGF medication every month for at least the past 3 months."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01792154", 
            "org_study_id": "RIH 1011"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Honolulu", 
                    "country": "United States", 
                    "state": "Hawaii", 
                    "zip": "96815"
                }, 
                "name": "Retina Institute of Hawaii"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Specular Photomicrograpic Assessment of the Effect of Anti-VEGF Intravitreal Injections on Corneal Thickness and Endothelial Cell Density and Morphology", 
        "overall_official": {
            "affiliation": "Retina Institute of Hawaii", 
            "last_name": "Michael D Bennett, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Data Safety Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Changes in corneal endothelial cell density and corneal thickness measured by changes in pachymetry and corneal cell count.", 
            "measure": "Specular Photomicrographic Assessment of the Effect of Anti-VEGF Intravitreal injections on corneal thickness and endothelial cell density and morphology", 
            "safety_issue": "No", 
            "time_frame": "Baseline, Month 6 and Month 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01792154"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Retina Institute of Hawaii", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Retina Institute of Hawaii", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}